Expansion of biotechnology co.'s operations at the Hillsboro site part of strategy to increase manufacturing capacity to meet demand.

Belgium co.'s facility to support mfg needs in the U.S. for Phase III clinical trial evaluating lead cardiovascular product candidate C-Cure.

Capital Investment, Community Impact Awards by TID show investment in the 10s of billions of dollars, new jobs top over 28,000.

Manufacturer of medical devices & software for treating cancer & supplier of X-ray imaging components to expand its Fulton County operations.

Cardio3 BioSciences will be based in Minnesota BioBusiness Center; its first U.S. facility.

Agreement offers up to $9M in performance-based incentives to create more than 750 jobs, investment of $26M in Wisconsin.

Digital platform helping healthcare payers power their digital strategies announced plans to expand its operations in Indianapolis.

Eighteen acres divided and sold to premier pharmaceutical companies InvaGen Pharmaceuticals and Alphamed Realty.